These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 30609219)

  • 1. Investigation of the Pentathiepin Functionality as an Inhibitor of Feline Immunodeficiency Virus (FIV) via a Potential Zinc Ejection Mechanism, as a Model for HIV Infection.
    Asquith CRM; Laitinen T; Konstantinova LS; Tizzard G; Poso A; Rakitin OA; Hofmann-Lehmann R; Hilton ST
    ChemMedChem; 2019 Feb; 14(4):454-461. PubMed ID: 30609219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Substituted 1,2,3-Dithiazoles as Inhibitors of the Feline Immunodeficiency Virus (FIV) Nucleocapsid Protein via a Proposed Zinc Ejection Mechanism.
    Asquith CR; Konstantinova LS; Laitinen T; Meli ML; Poso A; Rakitin OA; Hofmann-Lehmann R; Hilton ST
    ChemMedChem; 2016 Oct; 11(19):2119-2126. PubMed ID: 27511289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel fused tetrathiocines as antivirals that target the nucleocapsid zinc finger containing protein of the feline immunodeficiency virus (FIV) as a model of HIV infection.
    Asquith CR; Meli ML; Konstantinova LS; Laitinen T; Poso A; Rakitin OA; Hofmann-Lehmann R; Allenspach K; Hilton ST
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1352-5. PubMed ID: 25702849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the antiviral efficacy of bis[1,2]dithiolo[1,4]thiazines and bis[1,2]dithiolopyrrole derivatives against the nucelocapsid protein of the Feline Immunodeficiency Virus (FIV) as a model for HIV infection.
    Asquith CR; Meli ML; Konstantinova LS; Laitinen T; Peräkylä M; Poso A; Rakitin OA; Allenspach K; Hofmann-Lehmann R; Hilton ST
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2640-4. PubMed ID: 24813732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a Potential Inhibitor of the FIV p24 Capsid Protein and Characterization of Its Binding Site.
    Long M; Cantrelle FX; Robert X; Boll E; Sierra N; Gouet P; Hanoulle X; Alvarez GI; Guillon C
    Biochemistry; 2021 Jun; 60(24):1896-1908. PubMed ID: 34096272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and comparison of substituted 1,2,3-dithiazole and 1,2,3-thiaselenazole as inhibitors of the feline immunodeficiency virus (FIV) nucleocapsid protein as a model for HIV infection.
    Asquith CRM; Meili T; Laitinen T; Baranovsky IV; Konstantinova LS; Poso A; Rakitin OA; Hofmann-Lehmann R
    Bioorg Med Chem Lett; 2019 Jul; 29(14):1765-1768. PubMed ID: 31101470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of 1,2,3-dithiazole inhibitors of the nucleocapsid protein of feline immunodeficiency virus (FIV) as a model for HIV infection.
    Laitinen T; Meili T; Koyioni M; Koutentis PA; Poso A; Hofmann-Lehmann R; Asquith CRM
    Bioorg Med Chem; 2022 Aug; 68():116834. PubMed ID: 35653871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel epidithiodiketopiperazines as anti-viral zinc ejectors of the Feline Immunodeficiency Virus (FIV) nucleocapsid protein as a model for HIV infection.
    Asquith CRM; Sil BC; Laitinen T; Tizzard GJ; Coles SJ; Poso A; Hofmann-Lehmann R; Hilton ST
    Bioorg Med Chem; 2019 Sep; 27(18):4174-4184. PubMed ID: 31395510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.
    Medinas RJ; Lambert DM; Tompkins WA
    J Virol; 2002 Sep; 76(18):9079-86. PubMed ID: 12186891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of RNA Granule-Derived Capsid Assembly Intermediates Appears To Be Conserved between Human Immunodeficiency Virus Type 1 and the Nonprimate Lentivirus Feline Immunodeficiency Virus.
    Reed JC; Westergreen N; Barajas BC; Ressler DTB; Phuong DJ; Swain JV; Lingappa VR; Lingappa JR
    J Virol; 2018 May; 92(9):. PubMed ID: 29467316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a Conserved Interface of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Vifs with Cullin 5.
    Gu Q; Zhang Z; Gertzen CGW; Häussinger D; Gohlke H; Münk C
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurologic disease in feline immunodeficiency virus infection: disease mechanisms and therapeutic interventions for NeuroAIDS.
    Power C
    J Neurovirol; 2018 Apr; 24(2):220-228. PubMed ID: 29247305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-human immunodeficiency virus (HIV) agents are also potent and selective inhibitors of feline immunodeficiency virus (FIV)-induced cytopathic effect: development of a new method for screening of anti-FIV substances in vitro.
    Tanabe-Tochikura A; Tochikura TS; Blakeslee JR; Olsen RG; Mathes LE
    Antiviral Res; 1992 Aug; 19(2):161-72. PubMed ID: 1332602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa M. et K. and Sambucus nigra L.
    Uncini Manganelli RE; Zaccaro L; Tomei PE
    J Ethnopharmacol; 2005 Apr; 98(3):323-7. PubMed ID: 15814267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents.
    Gardner MB
    Antiviral Res; 1991 May; 15(4):267-86. PubMed ID: 1659310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced provirus burden and enhanced humoral immune function in AZT-treated SCID-feline mice inoculated with feline immunodeficiency virus.
    Johnson CM; Selleseth DW; Ellis MN; Childers TA; Tompkins MB; Tompkins WA
    Vet Immunol Immunopathol; 1995 May; 46(1-2):169-80. PubMed ID: 7618256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-gamma.
    Tanabe T; Yamamoto JK
    J Interferon Cytokine Res; 2001 Dec; 21(12):1039-46. PubMed ID: 11798461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feline immunodeficiency virus infection of cats as a model to test the effect of certain in vitro selection pressures on the infectivity and virulence of resultant lentivirus variants.
    Barlough JE; North TW; Oxford CL; Remington KM; Dandekar S; Ellis MN; Pedersen NC
    Antiviral Res; 1993 Dec; 22(4):259-72. PubMed ID: 8279815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral efficacy of nine nucleoside reverse transcriptase inhibitors against feline immunodeficiency virus in feline peripheral blood mononuclear cells.
    Schwartz AM; McCrackin MA; Schinazi RF; Hill PB; Vahlenkamp TW; Tompkins MB; Hartmann K
    Am J Vet Res; 2014 Mar; 75(3):273-81. PubMed ID: 24564313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.
    Giannecchini S; Di Fenza A; D'Ursi AM; Matteucci D; Rovero P; Bendinelli M
    J Virol; 2003 Mar; 77(6):3724-33. PubMed ID: 12610147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.